Philippe Marque

Philippe Marque

Auto-generated profile, based on publicly available information

Philippe Marque

Department of Physical and Rehabilitation Medicine, University Hospital of Toulouse, Toulouse, France

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 December 2017 in Brain Imaging and Behavior
Verified
Journal Article
Closed access
PDF file
NBNabila Brihmat
Nabila Brihmat
MTMohamed Tarri
Mohamed Tarri
YQYann Quide
Yann Quide
KAKetty Anglio
Ketty Anglio
BPBernard Pavard
Bernard Pavard
ILIsabelle Loubinoux
Isabelle Loubinoux

26 May 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
CFCamille Fakche
Camille Fakche
RVRufin VanRullen
Rufin VanRullen
PMPhilippe Marque
Philippe Marque
LDLaura Dugué
Laura Dugué
Spontaneous alpha oscillations (~10 Hz) have been associated with various cognitive functions, including perception. Their phase and amplitude independently predict cortical excitability and subsequent perceptual performance. Yet, the causal role of alpha phase-amplitude tradeoffs on visual perception remains ill-defined. We aimed to fill this gap and tested two clear predictions from the Pulsed Inhibition theory according to which alpha oscillations are associated with periodic functional inhibition. (1) High alpha amplitude induces cortical inhibition at specific phases, associated with low perceptual performance, while at opposite phases, inhibition decreases (potentially increasing excitation) and perceptual performance increases. (2) Low alpha amplitude is less susceptible to these phasic (periodic) pulses of inhibition, leading to overall higher perceptual performance. Here, cortical excitability was assessed in humans using phosphene (illusory) perception induced by single pulses of transcranial magnetic stimulation (TMS) applied over visual cortex at perceptual threshold, and its post-pulse evoked activity recorded with simultaneous electroencephalography (EEG). We observed that pre-pulse alpha phase modulates the probability to perceive a phosphene, predominantly for high alpha amplitude, with a non-optimal phase for phosphene perception between −π/2 and −π/4. The pre-pulse non-optimal phase further leads to an increase in post-pulse evoked activity (ERP), in phosphene-perceived trials specifically. Together, these results show that alpha oscillations create periodic inhibitory moments when alpha amplitude is high, leading to periodic decrease of perceptual performance. This study provides strong causal evidence in favor of the Pulsed Inhibition theory. Visual Significance Statement: The Pulsed Inhibition theory predicts that the functional inhibition induced by high alpha oscillations’ amplitude is periodic, with specific phases decreasing neural firing and perceptual performance. In turn, low alpha oscillations’ amplitude is less susceptible to phasic moments of pulsed inhibition leading to overall higher perceptual performance. Using TMS with simultaneous EEG recordings in humans, we found that specific phases of spontaneous alpha oscillations (~10 Hz) decrease cortical excitability and the subsequent perceptual outcomes predominantly when alpha amplitude is high. Our results provide strong causal evidence in favor of the Pulsed Inhibition theory.

9 May 2025 in JMIR Research Protocols
Verified
Journal Article
Open access
EMEmmeline Montané
Emmeline Montané
NBNabila Brihmat
Nabila Brihmat
CCCamille Cormier
Camille Cormier
CTClaire Thalamas
Claire Thalamas
VRVanessa Rousseau
Vanessa Rousseau
PMPhilippe Marque
Philippe Marque
Background: Individuals with poststroke hemiplegia often develop spasticity, which increases disability. Antispastic treatments such as baclofen and botulinum toxin are commonly prescribed in poststroke recovery. However, their impact on motor recovery, especially when administered within the first 2 months after stroke, remains unclear. Objective: This study aims to compare the motor recovery effects of botulinum toxin versus oral baclofen. The hypothesis is that botulinum toxin is more supportive of motor recovery than baclofen and enhances functional recovery. Methods: The study is a multicenter, controlled phase IV, comparative, prospective, randomized, double-blind, double-dummy, superiority trial to compare the toxin and baclofen, and a noninferiority trial to compare the toxin and the placebo. It focuses on the time course of the Fugl-Meyer Motor Assessment (FMA) as the primary outcome. The main inclusion criterion is patients with a single stroke in the past 2 months. Treatment comprises 1 intramuscular injection at treatment initiation and oral tablets for 4 months. Randomized patients are allocated to 3 arms: botulinum toxin with placebo baclofen, baclofen with placebo botulinum toxin, and placebo baclofen with placebo botulinum toxin. FMA scores are assessed at pretreatment, 1 month, and 3 months later. Spasticity, functional abilities, activities of daily living, pain, and quality of life are also evaluated. Adverse effects are monitored. A positive difference of 13 points in the FMA time course between the botulinum toxin and baclofen groups is considered a relevant effect. The data analysis plan involves linear regression models to compare primary and secondary outcomes, with adjustments for covariates such as age, center, and associated treatments. Subgroup analyses will examine proportional recovery profiles, and missing data in Fugl-Meyer scores will be addressed using imputation methods. Results: A total of 179 participants were randomized across 18 centers, with inclusions delayed due to the COVID-19 pandemic. As of December 2024, the data manager currently has all the data, and a review of data quality is in progress. No statistical analysis has been conducted so far, and the blind will be lifted after the analysis. Conclusions: This study identifies the most suitable spasticity treatment, considering the specificities of the stroke and constraints during the recovery phase. It will provide recommendations for the primary treatment of early spasticity post stroke. Trial Registration: ClinicalTrials.gov NCT02462317; https://clinicaltrials.gov/study/NCT02462317; European clinical trials (EudraCT) 2010-022881-28; https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-022881-28/FR International Registered Report Identifier (IRRID): DERR1-10.2196/62951

1 November 2021 in Annals of Physical and Rehabilitation Medicine
Verified
Journal Article
Open access
ACAlexandre Chalard
Alexandre Chalard
DADavid Amarantini
David Amarantini
CCCamille Cormier
Camille Cormier
PMPhilippe Marque
Philippe Marque
DGDavid Gasq
David Gasq

1 July 2012 in Progrès en Urologie
Verified
Journal Article
Closed access
LEL. Even
L. Even
JGJ. Guillotreau
J. Guillotreau
NMN. Mingat
N. Mingat
ECE. Castel-Lacanal
E. Castel-Lacanal
EBE. Braley
E. Braley
XGX. Gamé
X. Gamé

17 March 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
YKYue Kong
Yue Kong
KPKirsten Petras
Kirsten Petras
PMPhilippe Marque
Philippe Marque
RVRufin VanRullen
Rufin VanRullen
DADavid M. Alexander
David M. Alexander
LDLaura Dugué
Laura Dugué
Brain activity unfolds across space and time, giving rise to spatiotemporal dynamics that can manifest as cortical traveling waves –smooth phase shifts propagating across the cortex. Although traveling waves have been observed across species and measurement scales, their functional role in human cognition remains largely inferred from correlational evidence. In healthy humans, large-scale neural dynamics must be studied non-invasively, which provides limited access to their neural origins. Here, we tested whether global traveling waves causally contribute to inter-areal communication during attention. Using transcranial magnetic stimulation (TMS), we induced long-range traveling waves detectable with electroencephalography and assessed their neural and behavioral consequences during an attentional search task. Double-pulse TMS applied over the right frontal eye field transiently disrupted ongoing global waves and selectively induced direction- and frequency-specific traveling waves propagating toward the occipital visual cortex. These TMS-induced anterior-to-posterior theta traveling waves were rhythmically modulated by stimulation latency relative to search-trial onset. Critically, behavioral performance exhibited the same rhythmic pattern, with improved attentional search performance when TMS-induced traveling waves were more prominent. Together, these findings provide causal evidence that large-scale traveling waves support inter-areal communication during rhythmic visual attention.